1. Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study. (15th June 2021) Authors: Bankar, Aniket; Alibhai, Shabbir; Smith, Elliot; Yang, Dongyang; Malik, Sarah; Cheung, Verna; Siddiq, Nancy; Claudio, Jaime; Arruda, Andrea; Tsui, Hubert; Capo‐Chichi, Jose‐Mario; Kennedy, James A.; McNamara, Caroline; Sibai, Hassan; Maze, Dawn; Xu, Wei; Gupta, Vikas Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience. Issue 3 (June 2018) Authors: Alduaij, Waleed; McNamara, Caroline J.; Schuh, Andre; Arruda, Andrea; Sukhai, Mahadeo; Kanwar, Nisha; Thomas, Mariam; Spiegel, Jay; Kennedy, James A.; Stockley, Tracy; Tsui, Hubert; Devlin, Rebecca; Sibai, Hassan; Maze, Dawn; Schimmer, Aaron; Yee, Karen; Chan, Steven; Kamel-Reid, Suzanne; Gupta, ... Journal: HemaSphere Issue: Volume 2:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing. Issue 1 (January 2020) Authors: Khandelwal, Aditi; Phua, Chai W.; Chaudhry, Hina R.; Tsui, Hubert; Rivard, Georges E.; Teitel, Jerome M.; Sholzberg, Michelle Journal: Blood coagulation and fibrinolysis Issue: Volume 31:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Janus kinases restrain chronic lymphocytic leukemia cells in patients on ibrutinib: Results of a phase II trial. (17th November 2021) Authors: Spaner, David E.; Luo, Yuxuan; Wang, Guizhei; Gallagher, Jennifer; Tsui, Hubert; Shi, Yonghong Journal: Cancer medicine Issue: Volume 10:Number 24(2021) Page Start: 8789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lymphoid blasts with aberrant myeloid marker expression and BCR/ABL1: Is it mixed phenotype acute leukemia or B lymphoblastic leukemia?. Issue 1 (29th March 2021) Authors: Shopsowitz, Kevin E.; Shah, Kalpesh; Tsui, Hubert Journal: Cytometry Issue: Volume 102:Issue 1(2022) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Persistent janus kinase‐signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial. (7th March 2019) Authors: Spaner, David E.; McCaw, Lindsay; Wang, Guizhei; Tsui, Hubert; Shi, Yonghong Journal: Cancer medicine Issue: Volume 8:Number 4(2019:Apr.) Page Start: 1540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia. (December 2021) Authors: Chow, Signy; Tang, Kenny; Al-Abri, Mahmood; Hall, Victoria; Tremblay-Lemay, Rosemarie; Rashedi, Iran; Tsui, Hubert; Chan, Steven M. Journal: Leukemia research Issue: Volume 111(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗